Canada
BioVaxys Technology buys clinical studies management company TAETSoftware
TAETSoftware’s TAET has been designed to improve the tracking of adverse events and/or side effects in study participants.
MCI and uMed announce collaboration to increase trial access for patients
AB2 Bio concludes subject enrolment in trial of Tadekinig alfa for HLH
Diamond Therapeutics to give take-home psilocybin doses in Phase II trial
IMV reports positive data from Diffuse Large B Cell Lymphoma therapy trial
MediciNova gains approval from Health Canada for long Covid therapy trial
Nova Scotia Health selects Medable’s DCT platform to improve accessibility
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
